Carisma Therapeutics's total assets for Q3 2024 were $42.06M, a decrease of -29.12% from the previous quarter. CARM total liabilities were $53.18M for the fiscal quarter, a -9.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.